Author: Delaware Prosperity Partnership

Eastern Highway Specialists Increases Blue-Collar Opportunities in Wilmington

Eastern Highway Specialists Increases Blue-Collar Opportunities in Wilmington

Before Bob Field was hiring and training dozens of employees at Eastern Highway Specialists, his Wilmington-based infrastructure construction company of 18 years, he was working on the Delaware Memorial Bridge late at night, laying concrete – and the foundation of his new business.

“I would be out there till 3 a.m.,” Field said in his office on North Church Street, where EHS has operated since 2003. “I’d come home, go to sleep and wake up three hours later. When you start a business, you have to just be there and pay attention to everything, no matter what.”

EHS has come a long way from the small garage out of which Bob and his wife, Clair Field, founded their general contracting business. From developing pedestrian walkways and rehabilitating historic bridges to replacing bridge bearings on major highways like I-95, the firm has left its professional mark on how people travel throughout the Mid-Atlantic.

Bringing Blue-Collar Opportunities to Wilmington


Four years ago, Eastern Highway Specialists was at a crossroads.

Operating out of a 7,000 square-foot building on one acre of land, the heavy civil contractor needed to expand in order to hire more workers and buy equipment in bulk. Bob had added shop space over the years as his company increased from two employees to a 50-person workforce, but EHS had outgrown the North Church Street location. In 2017, it came time for EHS to start looking for new headquarters.

“The key is our growth in Wilmington,” Clair said. “There were places in other states that were close enough to consider, but with the emphasis on economic growth in the city, we really wanted to stay here.”

For the husband-and-wife team, Wilmington is home. They were both born at St. Francis Hospital about a year apart and had raised their eight children in the city.

Plus, Wilmington lies at the center of their bridge and highway projects, placing EHS within a 60-mile radius of highway construction sites throughout Delaware, Pennsylvania and Maryland.

EHS is a family business, with Bob serving as the company president and Clair as majority financial owner. Four of their children are also involved. They actively seek to increase the company’s diversity, with a third of EHS’s workforce comprising people of color.

So when Clair and Bob found property where they could build and develop a nearly 20,000-square-foot shop on five acres in Riverside, they jumped at the opportunity. The company’s $4 million investment on Downing Drive is nearly tripling their current space and adding four acres. Two grants approved by the state Council on Development Finance earlier this year are helping EHS bring 17 new positions to Riverside and improving existing infrastructure.

“These grants help offset some of the higher costs of developing land in former industrial cities such as Wilmington,” said safety and training manager Nathan Field. “It takes longer to return these areas to productive use today, and there are special associated costs.”

The cul de sac the company is adding to Downing Drive could potentially draw other businesses to the area.

“The grants will also help us upgrade Downing Drive, and it’s going to improve the desirability of doing business on this stretch for many other companies, too,” Nathan said.

Laying a Local Foundation

The new property not only benefits EHS as a company but also its workers, the surrounding Riverside community and future businesses.

Bob and Clair are invested in their workforce. They don’t want to hire people who leave after a few months. Every year, they sit down with employees to talk about next steps, so that their current positions can blossom into specialized careers.

“We are highly involved in developing a local workforce,” said Nathan, who is one of Clair and Bob’s sons.

As a participant in the Workplace Health and Safety Incentive Program for more than a decade, EHS is also committed to training employees on new skills and safety protocol. Since 2008, EHS has been continuously involved in the State of Delaware apprenticeship program as a sponsor. Nine of the company’s current employees graduated from the program, and four EHS foremen are apprentice graduates.

“We have to work from within,” Bob said. “As one example, we have someone who’s been with us for 10 years. He went through the apprenticeship program, and he’s now a certified welder.”

new blue-collar jobs with eastern highway specialistsThat means keeping blue-collar opportunities within walking distance, which is another reason EHS is staying in Wilmington’s East Side.

“People are choosing to invest here,” Nathan said, pointing to nearby REACH Riverside, a nonprofit that is improving the neighborhood through new housing projects.

By moving the construction company to the Riverside neighborhood, residents who don’t have cars will still have the opportunity to work for EHS.

“When there were factories, everybody was walking to work,” Nathan said of Wilmington’s industrial period. “When you’re rebuilding and creating new jobs in these areas, it’s a benefit to have companies that people can walk to.”

By redeveloping the Downing Drive site, the Field family is positioning EHS to be part of Wilmington’s growth and revitalization.

“We want to be part of the rise in the city,” Clair said.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Rob Rider Leads O.A. Newton to Record Growth

Rob Rider Leads O.A. Newton to Record Growth

1 October, 2021  LiveLoveDelaware.com

O.A. Newton CEO Rob Rider

For a business that has constantly reinvented itself over its 104 years in business, O.A. Newton & Son CEO Rob Rider doesn’t even pause when asked about his company’s elevator speech.

“We’re in two businesses – irrigation and farm and ranch products for a local customer base (Delmarva) and engineered material-handling systems on a national and international level,” says the fourth-generation leader (his grandfather Warren Newton was the “& Sons”).

Where many other Delaware businesses have struggled to survive during the pandemic, Rider says his company has been challenged to keep up as its building-product clients experience record sales and look to expand. For Rider, COVID 19 has been a business accelerant that has helped him grow revenues and move from 30 employees to nearly 40.

“Because we’re involved in both manufacturing and agriculture, we have been considered essential from the start, so we never laid anyone off,” he says. “At the beginning, we were getting ready to start a pretty large [composite decking] project and [the client] wouldn’t let us on site for a month. But that turned out to be a blessing because we were a bit behind schedule, and it allowed us to catch up and get the project back on schedule.”

Big box stores like Home Depot and Lowe’s saw a jump in business as homebound Delawareans decided to start or move forward with projects. As a result, demand for PVC pipe and fencing, vinyl siding, and wood composite decking stayed very strong.

At the same time, O.A. Newton continued to expand a longtime relationship with Miller Metal Fabrication, which leases space from Rider’s company.

“We decided 14 years ago that we didn’t need our employees doing the sheet metal fabrication for our products,” Rider says. “Miller Metal has developed a lot of advanced manufacturing to make our products better at a lower cost.”

For example, a few years ago, O.A. Newton identified a bottleneck in its production process involving a “spray and bake” painting process called powder coating that Miller Metal has been able to resolve. But Rider says client demand for the service has led them to offer the service to others from Harrington as an additional business.

“It’s not innovative and it’s not a new product,” Rider says. “You need to pay attention to what customers are asking for and then meeting the demand. It might only involve six or eight customers but there’s huge volume and we’ll be able to meet the demand together. You have to be ready to adapt.”

That discussion swung around to a question about O.A. Newton’s legacy after more than a century in Sussex County. The company got its start developing a feed for chickens that led to greater egg production, which led to feed-milling and chicken-breeding businesses. Beyond that, there is a dizzying list of businesses that Rob’s father Bob and then Rob himself started in response to customer needs and opportunities that they saw.

The commitment to innovation and being nimble led O.A. Newton to begin building conveyor belts to move the feed they milled in the 1950s. That led to the creation of conveying systems for companies that make plastic pipe and siding and decking and then to offering replacement parts and service when the recession slowed new construction. The company sold the poultry business was sold in 1969, and a parts counter became the O.A. Newton Farm and Ranch Store, essentially a specialty hardware store that recognized the changing demographics in Sussex and Kent counties from fewer large farms to more farmettes and hobby farms.

“As you can imagine, with our market being building products, the recession decimated our customers,” Rider says. “We had to really retrench and rebuild our business. When the housing bubble burst, it forced out a lot of inefficient manufacturing and we’ve seen steady growth since.”

The desire to stay nimble has led O.A. Newton to form partnerships with companies that have what they need, need what they have, or offer the scale to help them sell their products.

Rob Rider Remains an Unbashed Delaware Supporter


Since the start of the pandemic, the company has grown from 30 to nearly 40. Through it all, Rider has remained an unabashed Delaware supporter.

“Delaware has always been an easy place to do business,” he says. “Labor is easy to deal with and it’s easy to get answers. I can’t say that it’s always wonderful from a regulatory standpoint – that’s one of the things we need to work on — but it’s better than most. We’d never consider moving because of the experience we’ve had here.”

O.A. Newton recently shut down branch locations that served retail customers in New Jersey and New York for about 10 years because the “headache of doing business in those states wasn’t worth it. They weren’t terrible experiences, but in both cases, we just decided it wasn’t the right fit for us.”

Rider says he talks to people all the time who are considering renting space in his buildings or buying real estate to build themselves.

“I tell them we have a great workforce and the process to get located here from beginning to end is as easy and convenient as you’re going to get,” he says, adding that he completely supports the efforts of Bob Perkins and the Delaware Business Roundtable’s Ready in Six initiative to accelerate the permitting process.

Before ending the interview, Rider elaborated on his answer about the company’s legacy.

“I would hope that people are saying we’re keeping up with the times and exceeding their expectations, maintaining our relevance in today’s world,” says Rider. “Legacy to me really means reputation and one of the things that is more important than anything is being fair to our customers, our employees, and our community – pretty much in that order.”

“If we are not equally caring for all three of those stakeholders, then we’re not going to continue to exist. When we make decisions, we think about the impact tomorrow and 10 years from now.”

This article was originally posted on LiveLoveDelaware.com at: https://www.livelovedelaware.com/rob-rider-leads-o-a-newton-to-record-growth/

Kurt Foreman

PRESIDENT & CEO

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

New Report Details Growth and Opportunity for Delaware’s Life Sciences Sector

New Report Details Robust Growth and Immense Opportunity for Delaware’s Life Sciences Sector

Bioscience Life Science in Delaware report 2021

Study shows bioscience is leading economic driver in Delaware, generating $2B in GDP annually, with 11,000 employed in diverse sector jobs and state poised for significant expansion.
 
A comprehensive new report on Delaware’s life sciences vividly demonstrates the sector’s strength and recent growth, with 11000 jobs in the field, an annual economic impact of $2 billion in GDP, and a 65% increase in the number of new biotechnology R&D companies formed over the last 10 years.

Produced by Delaware Prosperity Partnership (DPP) and the Delaware BioScience Association (Delaware Bio), the study, “Life Sciences in Delaware: Momentum and Opportunity,” is the first comprehensive assessment of the breadth, depth and potential of the Delaware life sciences landscape.
 
The report analyzed five component subsectors capturing the full spectrum of bioscience activity in the state across private sector companies, higher education and nonprofit research institutions: Pharmaceuticals and Therapeutics; Research and Development, Testing and Medical Laboratories; Agricultural and Industrial Biosciences; Medical Devices and Equipment; and Supply and Distribution.
 
Key findings include:
 

  • Bioscience is a powerful economic driver in Delaware: The life sciences sector employs approximately 11,000 people and directly generates $2 billion in GDP (both 2.5% of total state employment and GDP) along with payrolls of at least $230 million.
  • Delaware’s bioscience landscape has transformed in recent years: The number of life sciences operations in Delaware has grown significantly in the past decade — most notably in the biotechnology R&D subindustry with an increase of 65% — and Delaware now ranks 7th nationally for life sciences venture capital funding per capita.
  • Delaware draws on a world-class talent pool in the statewide and regional labor market: Nearly 30% of all biochemists and biophysicists in the U.S. and one in six U.S. pharmaceutical employees works in Delaware’s region. The greater Philadelphia area ranks fourth in life sciences employment nationally, with Delaware employers drawing about one of five employees from across state lines.
  • Growth in federal funding has accelerated R&D activity: Since 2000, Delaware’s R&D funding from the National Institutes of Health has more than doubled, and the state is among the top three recipients per capita of funding from the NIH Institutional Development Award (IDeA) program. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), centered at the University of Delaware, recently opened a $156 million center for R&D and biopharmaceutical workforce training and, in July, received another $153 million in federal grants.
  • Delaware is home to an increasing, wide range of degree and training programs: The number of degrees in the life sciences disciplines awarded by Delaware institutions has grown by 64% since 2010.

Recent developments underscore significant momentum and opportunity for growth areas, including advanced manufacturing: These include the announcement of a several hundred-million-dollar-investment in a new pharmaceutical development and manufacturing facility in Middletown, hundreds of millions dollars more in investment planned for a new science and innovation park at a former DuPont site, a $10 million program supporting the expansion of lab space and one of 2020’s most successful biotech IPOs by a Delaware company.

Cementing Delaware’s position as a preeminent hub for the life sciences will require clear focus and collaboration across government, higher education and industry: The state is ideally situated to accelerate sector growth with sustained, strategic investment in workforce development, infrastructure and lab space, and improved university-industry engagement and access to capital. 

“This report confirms the exciting growth, vitality and great potential of Delaware’s life sciences sector,” said Governor John Carney, co-chair of DPP. “Our state has so many unique strengths and advantages within a thriving region. Ensuring Delaware is a top-tier global hub of life sciences research and innovation is essential to both public health and our economic future, and we will continue to invest in its long-term growth.”
 
“The COVID-19 pandemic has vividly demonstrated the enormous importance of the work biomedical researchers devote their lives to advancing,” said Delaware Bio President Michael Fleming. “With growth across every facet of our sector – from private businesses of every size to new degree and training programs and increased R&D investment and expanding manufacturing capacity – the Delaware bioscience sector has never been stronger, and this report provides a compelling roadmap for the life sciences’ role as a central driver of the state’s success while transforming the lives of the patients it serves.”  

“We are seeing both strong organic sector growth as well as a substantial increase in external interest by life science companies considering Delaware for their home,” said Kurt Foreman, DPP president and CEO. “The findings in this report make clear why the state has increasing momentum and appeal as an ideal location for life sciences companies to invest and grow.”

The complete report is available at choosedelaware.com/bioreport or by clicking here.

###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support private employers in identifying, recruiting and developing talent. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About the Delaware BioScience Association

Since 2006, the Delaware BioScience Association has been a catalyst for bioscience innovation in Delaware. Delaware Bio serves pharmaceutical and biotechnology firms, medical device manufacturers, agricultural biotech and chemical companies, research and testing companies, hospitals and medical institutions, academic partners and other organizations and related service companies, with the goal of expanding our state’s vibrant science economy.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Delaware Space Grant Consortium Launches Students into Innovation

Delaware Space Grant Consortium Launches Students into Innovation

delaware space grant program Dr. Muldrew

NASA is looking for more than a few good scientists, and Delaware is producing an abundance of them through NASA’s Space Grant program.

According to Dr. Milton Muldrow, chair of Science, Biology, and Environmental Science & Policy at Wilmington University and an associate director of the Delaware Space Grant Consortium, NASA’s National Space Grant College and Fellowship Project provides education and research resources for college-level students who have a potential future with the federal aeronautics and space agency.

NASA created the Space Grant program in 1989. Its national network includes more than 850 affiliates from universities, colleges, industry, museums, science centers, and state and local agencies. These affiliates belong to one of 52 consortia in all 50 states, the District of Columbia, and the Commonwealth of Puerto Rico.

Creating a Tech-Savvy Workforce for the Future


Through the Consortium, Delaware aims to contribute to the technologically literate workforce that NASA and other STEM entities will need in the years ahead.

“The project’s mission is to produce the workforce of the future for NASA,” Muldrow said. “They do this through research engagement for college students, internships and fellowship programs.”

The objectives of Space Grant are to encourage cooperative programs among universities, the aerospace industry, and federal, state and local governments, as well as interdisciplinary education, research, and public service programs related to aerospace. Space Grant also aims to promote a strong science, technology, engineering, and mathematics pipeline through higher education experiences. Muldrow’s introduction to the project came six years ago, when he became chair of Wilmington University’s science programs.

“After we developed science programs at Wilmington University, we immediately tried to align with Space Grant,” he said. “We wanted to offer more opportunities to our students.”

Since then, he added, several students have gotten involved and succeeded.

“My first student to receive a grant through the program created hundreds of maps of coral communities off the Florida Keys based off publicly available data,” Muldrow said. “She did amazing work.”

Interested students work with Muldrow, who submits a proposal to Space Grant based on his research goals. Students who participate in the program come away with tangible deliverables to offer potential employers in their chosen field, along with a notable affiliation.

“The name of the game, coming out of college, is no longer about just a degree,” Muldrow said. “Employers really want to see what you have done. And seeing that a potential employee has participated in a NASA project is a big deal for employers.”

The Space Grant program gives Delaware colleges and universities another means of producing valuable contributors to today’s innovation society.

“When our students get jobs at big labs and institutions, it shows the world the kind of talent we have in Delaware,” Muldrow said. “I’m just blown away every semester, not just by how intelligent the students are, but also how motivated they are.”

When students are accepted into the Space Grant program, they don’t just work on their projects. They also learn how to conduct themselves as scientists and comprehend the importance of being competitive. 

“The students learn skills such as working hard and going above and beyond because, at the end of the day, they’re competing with people globally for jobs,” Muldrow said. “Having that NASA banner next to your name is impressive, and our students go on to do great things.”

The Space Grant program also spotlights the work Delaware has contributed to the world of science and technology. Besides Wilmington University, the Delaware Space Grant Consortium includes the University of Delaware, Delaware Technical Community College, and Delaware State University. In Pennsylvania, Swarthmore College and Villanova University are participants. 

“It highlights the work that’s already being done in Delaware – work that people may not know,” Muldrow said. “Our director, Dr. William Matthaeus, is world-renowned. He helps develop satellites, including the Parker Solar Probe that launched to the sun.”

Through Space Grant, a group of Wilmington University students recently saw their work launched into space.

“The students helped to build a payload that takes various measurements while in space,” Muldrow explained. “This one went off into space from Wallops Island, Virginia, this spring. That is a national project, and to be represented on the national stage is putting Delaware innovation on the map.”

The student who produced maps of the ocean floor while still enrolled at Wilmington University was offered jobs in her field before receiving her diploma.

“She has moved up quickly,” Muldrow said. “She now works for DNREC – the Delaware Department of Natural Resources and Environmental Control – doing exactly what she did for us: she is a GIS specialist creating maps.”

Another recent graduate entered the Space Grant program with the primary goal of working in a lab. She procured a job at Merck, a pharmaceutical company, using Space Grant as her primary experience when she graduated. And she’s already been promoted.

An additional Wilmington University alum went on to the environmental engineering program at the University of Maryland, Baltimore County, which partners with NASA. 

“We have students participating in projects such as GIS mapping, policy research, biological research, and genetic engineering,” Muldrow said. “Our students have gone on to do some amazing things thanks to NASA’s Space Grant Project.”

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Miller Metal Fabrication Chooses to Grow in Southern Delaware

Full-service Manufacturer Miller Metal Fabrication Chooses to Grow, Consolidate Operations in Delaware

Miller Metal Fabrication in Southern Delaware

September 27, 2021 –

Increase in Manufacturing Capacity Will Bring New Employment Opportunities with Competitive Wages and On-the-Job Technical Training to Sussex County


WILMINGTON, Del. — Miller Metal Fabrication, a 26-year-old privately-owned regional metal fabrication company based in Bridgeville, Delaware, has chosen Delaware as the site for a planned expansion and consolidation of operations.

Miller Metal holds a unique position in its industry as a full-service provider. Unlike the majority of metal fabricators, Miller Metal provides “turn-key” solutions for its customers, as it designs, cuts, bends, welds, assembles and ships a wide range of metal components. Serving a large and diverse number of customers throughout the entire USA, the company specializes in highly sophisticated laser cutting, machining, forming, design engineering, welding and assembly services. Utilizing lean manufacturing techniques, Miller Metal maintains a constant goal of eliminating waste from manufacturing and administrative processes.

“Miller Metal Fabrication’s decision to expand their operations and build a new facility in Bridgeville is great news for Sussex County and for Delaware,” said Governor John Carney. “This expansion will create new jobs, and it reaffirms that Delaware is the ideal place for businesses to grow.”

Located in the Newton Business Park, just west of Route 13 on Route 404 in Western Sussex County, Miller Metal plans to build a 60,000-square-foot industrial / office building on 8.5 acres of land adjacent to its current leased facility. By increasing its manufacturing capacity, Miller Metal will be able to capitalize on its commitment to utilizing the latest technological fabrication advances, while continuing to support the growing needs of its existing and prospective customers across multiple industries.

“We strongly believe this new “world class” production facility will be an integral part of our long-term growth strategy,” said Martin W. Miller, founder and owner of Miller Metal. “We are extremely appreciative to have State of Delaware support in this effort.”

The company plans to consolidate 6 positions from its Greensboro, Maryland, shop upon completion of the building. It also estimates it will add 19 positions within three years from that date. With retention of 92 current jobs in Delaware, Miller Metal forecasts it will bring the total number of employees to 117 within three years.

Miller Metal offers competitive wages, full benefit packages that include 401K plan matching and subsidized health insurance. The company also offers on-site and remote technical training to its production workers.

Miller Metal Fabrication is investing almost $7 million in its new facility, including acquisition, construction and fit-out costs. Supporting the company’s plans are grants it has been approved to receive from the Delaware Strategic Fund by the State Council on Development Finance: a Jobs Performance Grant of $57,350 and a Capital Expenditure Grant of $207,900. Miller Metal previously received a Delaware Transportation Infrastructure Investment Fund Grant of $313,000 toward the construction of a new Route 404 entrance to the Newton Business Park – which facilitates future development by other businesses there as well.

“Sussex County is excited at the prospect of adding more good-paying jobs, thanks to Miller Metal Fabrication’s expansion plans and the approval of these grants,” said Sussex County Council President Michael H. Vincent. “Sussex County has a robust manufacturing sector, one that is thriving with many small and mid-size businesses. This funding will ensure another local company stays hard at work creating products that we can proudly say are made in America – and made right here in Sussex County.”

###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support private employers in identifying, recruiting and developing talent. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About Miller Metal Fabrication

For more than 25 years, Miller Metal has provided specialized services in the fabrication industry. With a commitment to customer satisfaction and competitive pricing, Miller Metal provides highly engineered metal products to a wide array of customers throughout the entire USA. Miller Metal made a commitment years ago to adhere to the principles of “lean manufacturing.” As such, the Company can provide cost-effective and timely solutions to its diverse customer base.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Siemens Healthineers Chooses Delaware for Expansion

Medical Technology Leader Siemens Healthineers Chooses to Grow, Develop New Product Lines in Delaware

Siemens Healthineers expands in Delaware

September 27, 2021 –

Global Company Will Invest Over $32M and Add 29,000 Square Feet to Its Glasgow Business Community Facility in Newark


WILMINGTON, Del. — Siemens Healthineers, which manufactures instruments, reagents and consumables across a range of laboratory diagnostic products, has chosen Newark, Delaware, as the site for a planned expansion and an increase in internal production capabilities that will allow the company to grow its product lines and stay competitive in its field.
 
The company plans to expand its current location in Building 100 of Glasgow Business Community by 29,000 square feet to add more capacity to manufacture up to 20 new in vitro diagnostic assays as well as additional associated calibrator products. Siemens Healthineers will also add new production equipment, including large-scale specialties and formulation process equipment. This growth will allow the company to reduce certain production outsourcing to contract manufacturers, retain well-paying jobs in Newark and further solidify its presence in Delaware for years to come.

“Delaware is a great place for innovative manufacturing companies like Siemens Healthineers to grow their operations,” said Governor John Carney. “We are pleased Siemens Healthineers will be making a significant investment in our state to enhance and expand their manufacturing facility, which will keep good-paying jobs here in Delaware.”

Siemens Healthineers currently has over 1,300 full-time employees, including approximately 500 employees in manufacturing and technical positions such as operators, technicians, chemists and engineers. Many employees have been with the company for decades.

A Key Player in Delaware’s Medical Technology Ecosystem

The company is one of the largest private employers and taxpayers in New Castle County and is an important player in Delaware’s medical technology ecosystem. The company is a member of the Delaware BioScience Association and partners with the University of Delaware for internships and provides scholarships to medical technology students. Siemens Healthineers is also involved in its community, with regular participation in local Juvenile Diabetes Association and American Heart Association fundraisers and other initiatives.

“New Castle County is excited to support Siemens Healthineers with its new investment in its existing facilities,” said New Castle County Executive Matt Meyer. “We are proud to see the company invest right here in our County at their expanded manufacturing facility. We look forward to future innovation and product development by Siemens Healthineers using our talented and world-class workforce, including the almost 500 highly-skilled manufacturing professionals.”

Siemens Healthineers is planning to invest more than $32 million into its expansion. Supporting the company’s plans are grants that the company has been approved to receive from the Delaware Strategic Fund by the state Council on Development Finance: a Retention Grant of up to $1.3 million and a Capital Expenditure Grant of up to $690,000. 

“The delivery of healthcare is evolving all over the world, including here in the United States. Expanding our operations in Delaware will allow us to better serve our customers and ultimately the patients they serve,” said Deepak Nath, PhD, President of Laboratory Diagnostics, Siemens Healthineers. “We have proudly been part of this community for decades, and investing in advanced medical technology here in Delaware allows us to produce products for export and better secure our supply chain for the future, while creating or preserving high-wage jobs and benefitting the community.”

The application was made by Siemens Healthcare Diagnostics Inc. It is wholly owned by Siemens Medical Solutions USA Inc., which is Siemens Healthineers AG’s U.S. holding company.  Siemens Healthineers currently owns approximately 135 acres and leases multiple facilities in the Glasgow Business Community and employs more than 1,300 full-time employees in Delaware.
 
###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support private employers in identifying, recruiting and developing talent. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at siemens-healthineers.com.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Delaware’s W. L. Gore & Associates Ranks 2nd on Fast Company’s Best Workplaces for Innovators List

Delaware’s W. L. Gore & Associates Ranks 2nd on Fast Company’s Best Workplaces for Innovators List

W. L. Gore & Associates innovators in Delaware

September 22, 2021 –

In 2021, following the year of the pandemic, one might have expected a short list of most innovative companies to have focused exclusively on COVID-19. But, in a year like no other we have experienced in our lifetimes, 60-plus-year-old W. L. Gore and Associates ranked second in Fast Company magazine’s 100 Best Workplaces for Innovators.

“Obviously, there’s a lot of pride,” says Anand Narayan, leader of Gore’s Innovation Center of Expertise (iCOE). “To be recognized for innovation, to be a place where innovators want to be, that’s really motivating.”

The center that Narayan leads was created over six years ago to counter a problem growing companies often face. When he arrived in 1994, the company had about 5,000 employees and annual revenues of $800 million. Today, there are about 11,000 employees and revenues are over $3.8 billion, with manufacturing sites in five countries and offices in 20 more.

“One of the challenges as you become bigger and bigger is that innovative practices can stall. We were still innovating, but a bit more cautiously,” Narayan says. “We needed a place where we can make bigger changes, take bigger chances. You need to be thinking about the next big thing in the spaces that you’re not in today.”

“One innovation can happen because you have one outstanding innovator,” Narayan explains, and that’s how Gore began its rise to prominence. But sustaining capability for innovation requires a supportive ecosystem, like the one Gore has created. 

Founded in 1958 by the husband-and-wife team of Bill and Vieve Gore, the company initially served the electronic products market. Then, in 1969, their son Bob discovered expanded polytetrafluoroethylene (ePTFE), a versatile polymer that would have applications in medical, fabric, biotechnology, oil and gas, aerospace, semiconductor and many other industries.

But Bob Gore was not just an outstanding innovator. He and Bill Gore fostered an environment that attracted and grew other innovators. Over time, its Associates have been responsible for more than 3,400 unique inventions in a wide range of fields, including electronics, medical devices and polymer processing – putting the company, and Delaware, on the global map as a premier venue for innovation.

A Workplace Empowering Innovators


Gore built its success – and continues to do so, Narayan says – because of its ecosystem, one that is driven by advanced materials, a desire to solve challenging societal problems and a deep belief in the potential of every individual to make a difference. Gore has a flat management structure that some have called a “workers’ democracy.” There still are individuals in leadership roles and some Gore Associates are responsible for making executive decisions, but all Associates are empowered to sign on to projects that pique their interests, align with their capabilities and are supported with investment by businesses.

“The world is full of opportunities,” Narayan says. “Ideas can come from anywhere. The question is how to decide which opportunities to take on.”

He offers this example:

“Someone from our Fabrics team went to a conference on probiotics, and he heard about the need to improve seaweed production. He came to the iCOE and said, ‘I heard something at the conference that looks interesting. Maybe we could explore this further.’”

innovators products at W. L. Gore DelawareThe Center paired a couple of Gore Associates with the Fabrics Associate – one from the business side, the other from the technical side. They looked more deeply into the idea and decided it was worth a try. Within months – and this was the blurb cited in the Fast Company listing – Gore had begun running commercial trials showing that their new process could improve yield by 40 percent in what is now a $16 billion global seaweed market.

“On the front end, it’s just a couple of people exploring,” Narayan says, and that exploration has several facets. Studying megatrends – climate change or population growth, for example – and brainstorming how the inventions of Gore Associates can be applied to solving some of the problems the megatrend presents is an important step in the process. “We look at market spaces that our divisions might not be involved in today, but where there could be a potential fit. Places where material science and technology can solve huge challenging problems in society are places where Gore is willing to take on high-risk opportunities.”

The preliminary research includes talking to current and prospective customers, for there’s little reason to proceed with developing a product that doesn’t solve a critical problem for potential customers. What the Associates learn from their exploration guides the Innovation Center in its decisions on whether to proceed, Narayan says. The end goal, he says, is “to make hard choices between good opportunities and great opportunities.”

Improving the odds of those choices doesn’t mean eliminating the risk involved but it does call for “de-risking,” or reducing the odds of failure.

Of course, in the world of science, success can never be a certainty. A rule of thumb in the profession, Narayan says, is that “only one out of 10 things you work on will probably be successful.”

Nonetheless, careful research within the iCOE has led Gore to continue its exploration of some high-risk opportunities.

Improving seaweed production is one example. So is the current work on creating an artificial cornea, a project now in its experimental stage in collaboration with the Johns Hopkins University School of Medicine in Baltimore. Damage to the cornea is the fifth-leading cause of blindness, according to a 2017 study, and successful development of an artificial cornea would reduce the need for cornea donations. 

“If we’re successful, there’s a whole body of patients who are blind who would benefit,” Narayan said.

Delaware – the Ideal Location for Innovators

The collaboration with Johns Hopkins calls attention to another of Gore’s assets – its location in Delaware.

Not only is the state well-regarded for its business-friendly climate, but its central location on the northeast corridor facilitates collaborations with research institutions in Baltimore and points south, not to mention Philadelphia and other science hubs to the north. The location is also a boon for recruitment, with Gore regularly reaching south to schools like Virginia Tech as well as from the University of Delaware, practically around the corner from the company’s home base in Newark.

Delaware is also an ideal place for a company like Gore to grow.

“Our plants are not usually very big, and so we tend to build multiple plants,” Narayan says. “In Delaware there’s plenty of space for us.

“We’re far enough from the big-city hullabaloo, but we have access to everything we need.”

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Delaware’s ANP Technologies Excels at Rapid Diagnostic Tests

Delaware’s ANP Technologies Excels at Rapid Diagnostic Tests

rapid diagnostic tests company ANP Technologies Delaware

Dr. Ray Yin has just 30 full-time people and some additional part-timers developing and producing rapid diagnostic tests for COVID-19 and bio-warfare and bio-threat agents and cancer treatments in their Newark, Delaware lab, doing the same thing that many of his competitors need 100 to 200 people to do.

“Our team is very efficient because of the type of expertise we have, and the flexibility of our platform technology based on nano-intelligent biomaterials, which means we save a lot of development cost and staffing needs when we go into a different area,” says the founder and CEO of ANP Technologies.

ANP is a clinical stage biotechnology company that is also developing pharmaceuticals for treating different types of cancer, including head and neck cancer, bile duct cancer, pancreatic cancer, and non-small cell lung cancers.

The biotech company’s proprietary platform, Nano Intelligent Detection System (NIDS), is used primarily in the detection area, particularly in areas where various rapid tests are based. But what makes his NIDS platform different is that it can be used to detect different targets with high sensitivity along with multiplexing.

ANP has developed a broad-spectrum cancer drug using nano-delivery technology that has been found to be very effective according to clinical trials and attracting the attention of potential partners or investors, Yin said.

Building Partnerships with Rapid Diagnostic Tests


The company got its start as part of the Army Research Lab in Aberdeen, Maryland, where it was solely focused on the development of rapid biological agent tests for the military. But it was spun off in 2002 as a private company led by Yin and has continued to work on rapid diagnostic tests and in the pharmaceutical drug-development area. The pandemic offered the company a huge opportunity to build a variety of partnerships with organizations trying to develop rapid testing.

“We have a dream to eventually go into the medical diagnostic and therapeutics areas,” says Yin. “Originally, we were only doing environmental detection, which is where biological warfare agent is focused on, in the air, water and surface. And now, we’re actually doing human sample testing from nasal fluid and blood as well as developing therapeutics to treat cancer patients.”

“We’ve gradually become a powerhouse in certain nano-biotechnology area, and particularly for the application perspective,” Yin said. “But to this point, we have not used much financing from the outside world, which I think could be even more interesting in terms of faster development.”

“We’re trying to find areas that are not crowded and where our technology has a unique niche where other people can hardly compete. For example, when we launched our biological warfare agent tests 15 years ago, we were the only one on the market at that time for rapid multiplex tests. And we still don’t have any competitors.”

Yin says ANP is collaborating with both academics like universities and cancer research centers, as well as federal government labs and pharmaceutical or diagnostic companies on joint inventions, patents, or products that have either been licensed, are seeking licensing, or are undergoing clinical testing.

Yin says the biggest barrier to success is the possibility of getting distracted by all the opportunities.

“The platform can be applied to many areas; there are many different targets in the diagnostic area and our technology can also be applied to therapeutic areas,” he says. “There are different kinds of drugs we can develop — either an old drug reformulated to become a better drug or a new drug that will enable us to compete in unmet medical need areas. The problem is that while our platform enables us to do many things, you need a lot of resources and funding to do that. And that has been a barrier. We have had to put ideas on the shelf because we didn’t have the resources to enter those businesses.”

During a recent interview, Yin shared his enthusiasm about one of ANP’s current studies – a test that returns results within 15 minutes assessing the effectiveness of various COVID-19 vaccines over time by determining whether participants are developing “neutralizing antibodies.” The neutralizing antibody level has been used as a biomarker to correlate with vaccine effectiveness in various clinical trials and after approval monitoring. The benefits could include being able to determine who needs to get a booster shot if they’re in short supply, helping employers determine how extensively they need to test their workforces; and potentially saving someone from having to get a booster they don’t need.

Yin says ANP’s work on COVID rapid testing is the ideal example for the benefits of its platform technology.

“We wouldn’t have been able to develop a COVID test so quickly without the platform, and because we have a [flexible] platform, now we have not only the antigen test, but also the neutralizing antibody test available where it can be used for various purposes.”

That said, ANP has had to move deliberately because the regulations constantly change, with different guidance on whether fully vaccinated people can get infected or whether fully vaccinated people can still infect others.  

Yin says the company chose to be in Delaware because being located only an hour or two away from its primary customer – the federal government — gave it a huge advantage of getting collaboration going or getting a new project initiated. 

Nanotechnology and Nano-biotechnology Talent in Delaware

The second advantage was the talent pool in Delaware in nanotechnology or nano-biotechnology.

“We’re loaded with talent here in Delaware, particularly with former DuPonters and Dow Chemical people. Great people are not easy to find. It’s not like you can go into Boston or the San Francisco Bay Area in this unique niche area. We’re looking for more of a nanomaterials-driven scientist for central research and development and we have the people who have [historically] worked for DuPont/Dow and the Army Research Lab (ARL), many of whom I brought with me or hired shortly after when I left ARL in 2002.”

Yin also said the company’s proximity to the University of Delaware enables ANP to recruit from there. In addition, many of the pharmaceutical companies he’s working with – or hopes to work with – are located within two hours in Pennsylvania, New Jersey, and New York.

He’s also hoping that ANP’s location will help him get funding from Wall Street.

“If we were not getting the federal funding, we would not have been able to survive. So, it’s actually something we need to pay attention to, how to attract the investors to basically beef up the companies in late stage and helping them to commercialize and or to finish the clinical trials.”

By the end of 2021, Yin hopes the company’s diagnostic test will be fully launched and FDA-approved and that its drug has also moved into the next stage of clinical trials.

“There are many things on our plate we’re trying to finish,” he said. “And we also think we will diversify ourselves even more by bringing more drug candidates and or diagnostic tests either to the final stage of development or to the market or get FDA approval as well.”

ANP recently won a highly competitive award of $20 million from National Institute of Health/Rapid Acceleration of Diagnostics (NIH/RADx) for the development of its COVID-19 rapid test. With the Delta Variant spreading so quickly, Yin believes the company will see significant revenue and employment growth once the FDA approve its test.

Yin also said he’s hoping to get more help with funding for the final stage of post-development commercialization.

“It’s hard to say that COVID is going to last forever, but right now it looks like it’s not going to go away quickly because the variants continue to emerge,” he says. “Delta arrived just three months ago and now 97% of the cases in the United States are all Delta.” 

“We’re learning as we go,” Yin said. “This virus is something completely new to humankind, and we just don’t know what we don’t know but we’re learning a lot from this process.”

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

The Innovation Space™ Expands Lab and Office Space for Startups

The Innovation Space™ Expands Lab and Office Space Available to Startups

The Innovation Space expands in Delaware

September 17, 2021 – 

50,000 Sq.ft.  Of Laboratory and Office Space Available April 2022


WILMINGTON, Del. – The Innovation Space™, an ecosystem with funding, resources, and programs tailored to accelerate and scale science-based startups, announced today that 50,000 ft2 of Class A laboratory and office space will be available in April 2022. This space, located in The Innovation Space’s Wilmington, Delaware headquarter building is comprised of 33 laboratories, 76 offices, and a network of shared conference rooms, collaboration spaces and amenities. Residential clients also gain access to the Experimental Station, a secure, 24/7 supported, innovation campus with a cafeteria, fitness center, exercise classes, and critical infrastructure support resources.

The lab and office footprint aims to enable biotechnology, chemistry, and material science startups as they grow and attain key milestones for expanded facilities. The space available in April 2022 is currently occupied by a large biotechnology client and supports both the advancement of their research and development of their business. Upon this client’s graduation from The Innovation Space in early 2022, the space will be made available to the next generation of startups and scaling companies.

“We are very pleased to be able to intensify our commitment to the growth of science-based startup companies and drive economic growth,” said Bill Provine, CEO of The Innovation Space. “This space would be a perfect fit for biotech or chemistry-based companies and can support multiple smaller growth companies or be a great home for a rapidly scaling larger company.”

“The Innovation Space has been a critical partner for Prelude Therapeutics in support of our rapid growth,” said Kris Vaddi, CEO of Prelude Therapeutics. “We continue to gain value from their entrepreneur-first business focus and flexible engagement strategies which have provided us with the framework to expand our company with them from 5 employees in 2017 to over 100 employees today,” said Vaddi.

“Whether you are just starting out your journey as a science entrepreneur or are have recently raised a multi-million-dollar round of investment, you will find supportive programs and capabilities across The Innovation Space that will enable you to move your startup forward more aggressively,” said Provine. “We are an entrepreneur-first organization and have both physical assets such as leveraged scientific equipment and world-class laboratory capabilities in addition to our supportive suite of business building programs. These programs include our First Fund™ where we provide investment, our Science INC™ cohort-based accelerator where we work intensely over a four month program with early startups on their business models and connect them with partners and investors, and our Spark Factory™ mentoring program where we provide access to and advice from seasoned functional experts and business leaders.”

About The Innovation Space™:

The Innovation Space is a multi-dimensional, non-profit entrepreneurial support organization and an ecosystem where entrepreneurs, scientists, business leaders, community members, investors, and service providers in the advanced materials, industrial and agriculture biotechnology, chemical ingredients, renewable energy, nutrition, therapeutics, diagnostics, and healthcare fields can build business concepts together and accelerate the path to commercialization of each startup. The Innovation Space was formed from a public-private partnership between the State of Delaware, DuPont, and the University of Delaware. The Innovation Space™ is also known as Delaware Innovation Space™ and the Home for Science Entrepreneurs™.

Learn more: innovationspace.org; https://bit.ly/TheInnovationSpace; and www.firstfund.org.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Adesis Announces Expansion at Delaware’s DuPont Experimental Station

Adesis Announces Expansion at Delaware’s DuPont Experimental Station

Adesis expands at DuPont Experimental Station

Adesis, Inc., a leading contract research organization and a wholly-owned subsidiary of Universal Display Corporation (Nasdaq: OLED), today announced a new state-of-the-art laboratory expansion to support its growing research and development pipeline. Situated in Wilmington, Delaware, this expanded lab space approximately triples Adesis’ footprint in the DuPont Experimental Station.

“The new lab expansion in the Experimental Station increases our research footprint and broadens our capabilities for discovering, developing and designing critical chemistry solutions,” said Andrew Cottone, Ph.D., President of Adesis, Inc. “For nearly a century, the DuPont site has contributed to Delaware’s reputation as a leader in chemical research and development, and we are proud that Adesis is part of that remarkable legacy.” 

“Adesis has a strong track record of growth and innovation, and we are pleased to see their continued expansion at the Experimental Station,” said Governor John Carney. “This is another example of how Delaware remains a great place for businesses of all sizes to put down roots, grow, and create jobs.”

 The Adesis team worked closely with the office of Gov. John Carney and Becky Harrington and Kurt Foreman at the Delaware Prosperity Partnership (DPP), who were integral in facilitating the search and securing the Experimental Station agreement. This increased capacity will allow Adesis to extend its expertise and service offerings across a broader range of opportunities.

 “Supporting Adesis’ growth in Delaware has been very gratifying for the DPP team to be a part of. As a leading chemical contract research organization, Adesis plays an important role in enhancing Delaware’s vibrant science sector,” said Kurt Foreman, President and CEO of Delaware Prosperity Partnership. “Andrew Cottone and his team are doing great work. We look forward to celebrating Adesis’ continued growth.”

Cottone continued, “This expansion is the result of the continued growth Adesis has experienced since we first moved into the Experimental Station in 2017. We’re incredibly appreciative of state and local support, from Governor Carney, to the DPP, to Delaware Innovation Space (DISI) CEO and President, William Provine.”

About Adesis, Inc.

As a wholly-owned subsidiary of Universal Display Corporation, Adesis is a contract research organization (CRO) supporting the pharma, biotech, catalysis and a number of other industries. The CRO specializes in organic and organometallic synthesis, in milligrams to multi-kilogram quantities. Adesis has a business model of providing clients with organic chemistry services in three areas: early stage research, scale up and development, and specialty manufacturing. With over 20 years of success and approximately 100 chemists with extensive industry and professional experience, Adesis supports companies in various industries with small molecule organic chemistry expertise. Adesis provides a range of services that can supplement research and development efforts. It can also act as a specialty manufacturer to reinforce supply chains and protect sensitive intellectual property. To learn more about Adesis, please visit http://adesisinc.com/.

About Universal Display Corporation

Universal Display Corporation (Nasdaq: OLED) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. To learn more about Universal Display Corporation, please visit https://oled.com.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Market Pressure Relief Fund Available for State Contractors

Market Pressure Relief Fund Available for State Contractors

Delaware state contractors market pressure relief fund

The Delaware Division of Small Business continues to accept applications for the Market Pressure Relief Fund. The relief fund is designed to assist state contractors facing increased costs for construction materials due to the pandemic.

The fund can provide adjustment reimbursements for non-transportation construction materials purchased from January 1 through July 31, 2021. General contractors who have a contract with the state resulting from a formal procurement can apply for assistance from the fund. 

Applications Deadline is September 30th


Applications will be accepted through September 30, 2021. If you need assistance filling out the application or have questions, please call 302-739-4271 and ask to speak with a business manager.

Click on the Market Relief Pressure Fund application link to complete the form.   

This article was originally posted on the Delaware Division of Small Business website at:  https://business.delaware.gov/market-pressure-relief-fund/

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Health Care Student Loan Forgiveness Programs Attract Doctors and Nurses in Delaware

Delaware’s Health Care Loan Forgiveness Programs Attract Doctors and Nurses to Delaware

delaware student loan repayment programs for medical professionals

August 30, 2021 –

Delaware is advancing healthcare access statewide by offering a pair of student loan repayment programs that encourage qualifying medical professionals to choose Delaware for their practice.

A shortage of healthcare professionals – especially primary care practitioners – is being felt throughout the United States. But Delaware is staving off the service delays and delivery gaps that can be caused by this shortage by attracting much-needed medical personnel to the First State with a pair of programs that help them cover the cost of their education and training.

Delaware has been known for its Delaware Student Loan Repayment Program for healthcare providers since the program was established in 2001. In fact, an article by Money magazine identifies Delaware as one of “11 states and cities that will help you pay off your student loans.” In 2021, the Delaware Health Care Provider Loan Repayment Program was created to strengthen Delaware employer efforts to recruit and retain quality healthcare professionals even further.

“Delaware may be a tiny state,” the Money article notes, “but it is offering big bucks to healthcare professionals looking to move and work there.”

Two Delaware Health Care Provider Loan Repayment Programs Available


Details of the two programs offered in Delaware are as follows:

  • The newly created Delaware Health Care Provider Loan Repayment Program offers grant awards up to $50,000 per year for a maximum of four years to new primary care providers who have recently completed their graduate education. Administered by the Delaware Health Care Commission, the program serves family medicine physicians, specialists, nurse practitioners, certified nurse midwives, and physician assistants. Priority consideration may be given to Delaware Institute of Medical Education and Research-participating students and participants in Delaware-based residency programs.

In addition, hospitals, private practices, and other healthcare organizations may apply for grants on behalf of their qualifying employees. All facilities or organizations submitting applications must accept Medicare and Medicaid patients and be located in underserved areas or areas of need. Any hospitals submitting applications also must pledge a dollar-for-dollar match.

“Our primary care doctors and their teams are the first line of defense in our healthcare system and the personal time they spend with their patients helps create healthier communities one family at a time,” Delaware State Representative Bryan Shupe. “Investing in the future of our local doctors, through this public-private partnership, will set a precedent in focusing on our local communities and the health of our local families.”

Further details about the Delaware Health Care Provider Loan Repayment Program are available here.

  • In place since 2000, the Delaware Student Loan Repayment Program offers awards ranging from $30,000 to $100,000 for up to four years to healthcare professionals who live in Delaware and work in designated Health Professional Shortage Areas. Administered by the Delaware Department of Health and Social Services, the program serves qualified advanced and mid-level professionals in dental, behavioral/mental health and primary care and is open to both recent graduates considering moving to or staying in Delaware as well as to practitioners already employed for several years by a qualified Delaware practice site.

A flyer about the Delaware Student Loan Repayment Program may be downloaded here

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading